Log in

COVID-19 Information Page

The following updated guidance was released on September, 9th, 2020. “The U.S. Department of Health and Human Services (HHS), through the Assistant Secretary for Health, issued guidance under the Public Readiness and Emergency Preparedness Act (PREP Act) to expand access to safe and effective COVID-19 vaccines when they are made available. This guidance authorizes state-licensed pharmacists to order and administer, and state-licensed or registered pharmacy interns acting under the supervision of the qualified pharmacist to administer, COVID-19 vaccinations to persons ages 3 or older, subject to certain requirements…The authorization preempts any state and local laws that prohibit or effectively prohibits those who satisfy these requirements from ordering or administering COVID-19 vaccines as set forth above. The authorization does not preempt state and local laws that permit additional individuals to administer COVID-19 vaccines to additional persons.”

You can read more information at the link below.


Dear NH Licensed Pharmacist:

Due to the COVID-19 State of Emergency, and as outlined in Exhibit H to Emergency Order #29, the Office of Professional Licensure and Certification (OPLC) is waiving Continuing Education (CE) requirements for all OPLC licensees renewing from March 13, 2020 to December 31, 2020.  As all NH licensed pharmacists are due to renew by December 31, 2020 – CE requirements are waived for all pharmacists this renewal cycle.  Now that pharmacist licenses are on a biennial renewal schedule, you will therefore not be required to submit any CE documentation for calendar years 2019 – 2020 when you complete your online pharmacist renewal this November-December 2020.  Pharmacists must again begin earning CE as of January 1, 2021.

For other COVID-19 related news and resources, please see the Board’s COVID-19 resource page at: https://www.oplc.nh.gov/pharmacy/covid-19-info.htm

New Hampshire Board of Pharmacy
Division of Health Professions  |  Office of Professional Licensure & Certification
Philbrook Building, 121 South Fruit Street, Suite 401, Concord, NH 03301-2412

Expanding Access to COVID-19 Testing by Licensed Pharmacists - Emergency Order #47

Remdesivir Receives Emergency-Use Authorization  
The search for an effective treatment for COVID-19 has a leading candidate— remdesivir. Widespread media coverage is sure to have patients asking pharmacists when it will be available and whether they can get it, even though it is only administered IV in hospitals. Still, it’s a bright spot in a time and on a subject that has had very little good news. Here’s the latest on trials for the drug and what the emergency authorization means for patients.

The Drug Enforcement Administration (DEA) is providing the following guidance regarding the issuance of oral schedule II prescriptions in light of the nationwide public health emergency (“Public Health Emergency”) declared by the Secretary of Health and Human Services (HHS) on January 31, 2020, pursuant to section 319 of the Public Health and Service Act, 42 U.S.C. 247d

COVID-19 - Federal DEA Controlled Drug Prescription Guidance - National State of Emergency


During this National Emergency the Diversion Control Division will continue to work with its Federal partners, DEA registrants, and their representative association to assure that there is an adequate supply of controlled substances in the United States. The DEA will also work to assure that patients will have access to controlled substances.

On March 16, 2020, the DEA published a COVID-19 Information Page on the Diversion Control Divisions Web Site. This page contains important guidance concerning COVID-19 and the national drug supply, electronic prescribing of controlled substances, telemedicine, medicated assisted treatment, and other important federal and state information. This site will be updated frequently as new information and guidance is issued. Please check back frequently for further information.

DEA Decision Tree

TO:   All NH Licensed Pharmacists and Pharmacies

Dear Licensee:

Pursuant to Emergency Order #47, licensed Pharmacists may initiate, order, administer, and analyze COVID-19 test kits, provided:

1.The pharmacist has received the adequate education and training to initiate, order, administer, and analyze COVID-19 test kits;

2.The COVID-19 tests are administered at a pharmacy that holds the appropriate clinical laboratory improvement amendments (CLIA) certificate and a New Hampshire laboratory license issued by the Health Facilities Administration of the New Hampshire Department of Health and Human Services (DHHS). Alternatively, tests may be administered at a pharmacy with a DHHS waiver, pursuant to DHHS’s authority to waive licensure requirements when it deems appropriate health and safety standards are met; and

3.The pharmacy creates and implements policies and procedures to address the collection, storage, transport, and analysis of samples collected as a result of administering and analyzing COVID-19 test kits. Such policies and procedures shall be in line with the manufacturer’s instructions and supplemented as needed.
In order to ensure the New Hampshire Department of Health and Human Services (DHHS) – Health Facilities Administration is able to adequately respond to your request for temporary approval to conduct COVID-19 testing in accordance with Emergency Order #47, we kindly ask you to submit your request in writing to the following email address: DHHS.hfaregcorrespondence@nh.gov  
For all pharmacies with a current laboratory license, please provide the following information when submitting your request for temporary waiver of collection site licensure:

1. Name of Licensee;
2. Email address and phone number of Contact Person;
3. Address of pharmacy;
4. Proposal for collection, storage, transport, and analysis of samples collected (including the name of the EUA test).   

For ALL OTHER pharmacies, please provide the following information when submitting your request for temporary waiver of laboratory and collection site licensure:

1. Name of Pharmacy;
2. Name of Contact Person;
3. Email address and phone number of Contact Person;
4. Address of pharmacy; 
5. Proof of CLIA certificate;
6. Proposal for collection, storage, transport, and analysis of samples collected (including the name of the EUA test).  

Once we receive this information we will work on processing your requests. We ask that all questions pertaining to your request, also be directed to the DHHS.hfaregcorrespondence@nh.gov mailbox.  Please note, missing or incomplete requests will only result in processing delays.  

Thank you all, please disseminate to others as appropriate.

Kelly Keefe, RN
Clinical Supervisor
NH Department of Health and Human Services
Health Facilities-Licensing
129 Pleasant Street
Concord, NH 03301

New Hampshire Board of Pharmacy
NH Office of Professional Licensure & Certification
Philbrook Building, 121 South Fruit Street, Suite 401, Concord, NH 03301-2412
Website: www.oplc.nh.gov/pharmacy

COVID-19 Resources for NH Pharmacists

The COVID-19 pandemic is an ever-evolving situation. At NHPA will do our best to keep our members advised of information that is relevant to pharmacy practice in NH. Please check out our website and follow us on Facebook and Twitter for updates.

Here are some important updates for this week:

Based on these emergency provisions, pharmacists may refill maintenance medication prescriptions that are out of refills for a 90-day supply WITHOUT the authorization of the provider.

CDC recommends that people contact their healthcare provider to obtain extra medications in case there is an outbreak of COVID-19 in the community and people need to stay home for a prolonged period of time. As a result, medical offices are being inundated with refill requests from patients. Pharmacists can reduce this burden by following this emergency provision.

This is also a key time to stress medication adherence with your patients that have underlying medical conditions. According to CDC, COVID-19 illness may be more severe in individuals with certain underlying medical conditions especially if they are not well controlled.

NHPA has created a COVID-19 forum for our members.  If you are interested in this service and are a current member of NHPA, please sign up at our website . You can use this forum to communicate with other pharmacists and technicians in the state.


NH Board of Pharmacy COVID-19 Page

Request for Healthcare Professional Volunteers – COVID19 Response

The NH Department of Health and Human Services (NH DHHS), along with the Office of Professional Licensure and Certification (OPLC) are looking for healthcare professionals to volunteer.  Those healthcare professionals who are not currently working in a healthcare facility and who may be furloughed, retired or otherwise interested in helping with the COVID-19 response are needed by the community.   

Our community is prepared to facilitate a response to the surge, we are asking for all available healthcare professionals to assist.  Responsibilities may include direct or indirect care of existing or new patients in a variety of settings. If you are able to respond, please go to nhresponds.org and complete the brief registration process. In this unprecedented, rapidly evolving situation, we thank you for your consideration to aid the State’s effort to continue to protect and serve NH residents. 



WHEREAS, since December 1, 2019, there have been over 952,171 people worldwide diagnosed with a novel coronavirus disease now known as coronavirus disease 2019 (COVID-19);

WHEREAS, on March 13, 2020, His Excellency, Governor Christopher T. Sununu, issued Executive Order 2020-04 declaring a state of emergency due to COVID-19;

WHEREAS, there are now more than 540 people who have tested positive in New Hampshire for COVID-19 and numerous other suspected cases are under investigation;

WHEREAS, the Department has been monitoring reported drug shortages and finds that there is a statewide shortage and/or threatened shortage of the following medications that may be used to treat COVID-19: chloroquine, hydroxychloroquine, and albuterol inhalers; and

WHEREAS, the Commissioner has determined individuals diagnosed with lupus or rheumatoid arthritis, those hospitalized patients with COVID-19, and those patients with COVID-19 enrolled in a clinical trial are high risk or critical needs groups that shall receive priority for chloroquine and hydroxychloroquine; and

WHEREAS, the Commissioner has determined individuals diagnosed with COVID-19 and individuals already established on albuterol inhalers are high risk or critical needs groups that shall receive priority for albuterol inhalers; and

WHEREAS, to ensure individuals in the high risk or critical needs group have access to necessary medications, and to avoid any disruptions to current treatments, the Commissioner finds it is necessary to control, restrict, and ration chloroquine, hydroxychloroquine, and albuterol inhalers.

Now therefore, in consultation and with concurrence of His Excellency, Governor Christopher T. Sununu, and pursuant to RSA 21-P:53, III, it is hereby ordered, effective immediately, that:

  1. Chloroquine, hydroxychloroquine, and albuterol inhalers shall be subject to the following controls, restrictions, and rationing:

a) Outpatient prescriptions for patients not already established on chloroquine and hydroxychloroquine shall be limited to a 30-day supply.

b) No prescriptions of chloroquine or hydroxychloroquine shall be issued or dispensed as prophylaxis treatment for COVID-19. 

c)  Prescribing providers, when issuing a prescription in any form for chloroquine or hydroxychloroquine, must document an indication for all patients, including patients already established on these medications.

d) For albuterol inhalers, prescribing providers shall limit prescriptions to one inhaler with up to three refills for all new prescriptions to treat respiratory symptoms of COVID-19.  

e)  For all prescriptions of albuterol inhalers, pharmacists shall conduct a prospective drug utilization review to ensure adherence to asthma controller or maintenance medications, and counsel patients that are non-compliant and over-utilizing rescue inhalers.

  1. This Order shall remain in effect until the State of Emergency declared by the Governor is terminated, or this Order is rescinded, whichever shall happen first.

New Hampshire Pharmacists Association 

373 South Willow Street  D1-1, Suite 165

Manchester, NH 03103

Email: info@nhpharmacists.net

NHPA Mission Statement

The mission of the New Hampshire Pharmacists Association is to promote, enhance, and advance pharmacy practice, in the State of New Hampshire by advocating for the professional interests of pharmacists, pharmacy technicians, student pharmacists, and ancillary pharmacy personnel as well as to advocate for the health and welfare of the general public.

Signup For Our Mailing List

You will only receive notification about our CE Programs, Dinner Social Events, and legislative alerts. Our list is never shared or sold for any reason.

Event Cancellation Policy

Your NHPA website has been updated and is now smartphone friendly.

Please take the time to view the website from your laptop as well as from your smartphone. 

We look forward to your comments and suggestions.

Powered by Wild Apricot Membership Software